Literature DB >> 15694593

Do molluscs possess indoleamine 2,3-dioxygenase?

Hajime Julie Yuasa1, Tomohiko Suzuki.   

Abstract

Indoleamine 2,3-dioxygenase (IDO)-like myoglobin (Mb) was discovered in 1989 in the buccal mass of the abalone Sulculus diversicolor, and it has since been isolated from several archaegastropods. The amino acid sequences and genomic structures of IDO-like Mbs show significant homology with those of mammalian IDOs, suggesting that they have evolved from a common ancestral gene. However, details of the evolutionary relationships between them remain unknown. Here, we isolated a novel multicopy gene from Sulculus named molluscan IDO-like protein (MIP). The amino acid sequences of MIPs show the highest homology (about 60% identity) with Sulculus IDO-like Mb, and their exon/intron structures are also highly homologous. However, MIPs are mainly expressed in the gut whereas IDO-like Mb was found only in the buccal mass, suggesting that MIPs are not simply isoforms of IDO-like Mb. A bacterial expression study showed that MIP is a heme-binding protein, and that His335 is the proximal ligand of heme. Although we could not detect IDO activity using a recombinant glutathione S-transferase (GST)-MIP fusion protein in the present study, MIP should have some function other than that of an oxygen carrier like myoglobin, and it might in fact be molluscan IDO.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15694593     DOI: 10.1016/j.cbpc.2004.11.007

Source DB:  PubMed          Journal:  Comp Biochem Physiol B Biochem Mol Biol        ISSN: 1096-4959            Impact factor:   2.231


  2 in total

1.  Molecular evolution and characterization of fungal indoleamine 2,3-dioxygenases.

Authors:  Hajime J Yuasa; Helen J Ball
Journal:  J Mol Evol       Date:  2010-12-18       Impact factor: 2.395

2.  Evolution of vertebrate indoleamine 2,3-dioxygenases.

Authors:  Hajime Julie Yuasa; Miwa Takubo; Ayumi Takahashi; Tetsuo Hasegawa; Hiroshi Noma; Tomohiko Suzuki
Journal:  J Mol Evol       Date:  2007-11-17       Impact factor: 2.395

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.